P080 Efficacy and Safety of Docetaxel Plus Ramucirumab: A Consecutive Analysis of 68 Patients With Advanced NSCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.10.093
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Retrospective Study of the Safety and Efficacy of Paclitaxel Plus Ramucirumab in Patients With Advanced or Recurrent Gastric Cancer With Ascites

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

P2.01-34 Prognostic Value of Neutrophil to Lymphocyte Ratio for Metastatic NSCLC Patients Treated With Immunotherapy and Ramucirumab Plus Docetaxel.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

The Efficacy and Safety of Immunotherapy in Patients With Advanced NSCLC: A Systematic Review and Meta-Analysis

Scientific Reports
Multidisciplinary
2016English

Clinical Efficacy and Safety of Nimotuzumab Plus Chemotherapy in Patients With Advanced Colorectal Cancer: A Retrospective Analysis

Journal of International Medical Research
BiochemistryMedicineCell Biology
2020English

P1.01-34 Docetaxel Plus Ramucirumab With Prophylactic PEG-G-CSF Support for Chemo-NaïVe Elderly NSCLC Patients: A Phase II Study (WJOG9416L)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Tracheoesophageal Fistula in a Patient With Advanced NSCLC Who Received Chemoradiotherapy and Ramucirumab

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

P3.17-09 Retrospective Analysis of the Efficacy and Safety of Multimodal Treatment for Locally-Advanced NSCLC in Elderly Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MA26.10 CNS Activity of Ramucirumab in Combination With Osimertinib in Patients With Advanced T790m-Positive EGFR-Mutant NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.01-40 Randomized Phase II Study of Docetaxel Plus Bevacizumab or Pemetrexed Plus Bevacizumab for Elderly PTS With Untreated Advanced NSCLC: TORG1323

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy